CVR: 81814813
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Ulrikke Lynge Jensen and Anja Wencke van Arkens. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees. In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity amounted to DKK 10,525,639.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive famaceutisk-medicinsk- og lignende konsulent- og agenturvirksomhed, samt dermed i forbindelse såtende virksomhed
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2026 | 38.8 mio. | 10.2 mio. | 15.8 mio. | 10.5 mio. | 24 | |
| 2025 | 31.2 mio. | 6.1 mio. | 12.3 mio. | 6.5 mio. | 21 | |
| 2024 | 24.8 mio. | 3.4 mio. | 6.9 mio. | 3.7 mio. | 19 | |
| 2023 | 29.1 mio. | 4.9 mio. | 8.9 mio. | 5.3 mio. | 21 | |
| 2022 | 30.2 mio. | 6 mio. | 10.4 mio. | 6.3 mio. | 21 | |
| 2021 | 25.6 mio. | 5.5 mio. | 9.4 mio. | 5.9 mio. | 19 | |
| 2020 | 21.4 mio. | 3.8 mio. | 8.1 mio. | 4.1 mio. | 16 | |
| 2019 | 17.5 mio. | 2.5 mio. | 5.4 mio. | 2.8 mio. | 14 | |
| 2018 | 17.1 mio. | 3.7 mio. | 6.8 mio. | 4 mio. | 13 | |
| 2017 | 14.6 mio. | 2.1 mio. | 4.8 mio. | 2.4 mio. | 13 | |
| 2016 | - | 2 mio. | 4.6 mio. | 2.3 mio. | - | |
| 2015 | 9.7 mio. | 636 t. | 3.1 mio. | 956 t. | - | |
| 2014 | 9.7 mio. | 517 t. | 5.3 mio. | 1.5 mio. | - | |
| 2013 | 9.4 mio. | 728 t. | 4.3 mio. | 2.4 mio. | - |
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringCompared to 1.164 companies in Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
BILLEV PHARMA ApS has published its annual report for 2026. Gross profit came to DKK 38,801,270, and the net result was DKK 10,205,639.
BILLEV PHARMA ApS has published its annual report for 2025. Gross profit came to DKK 31,189,057, and the net result was DKK 6,143,854.
BILLEV PHARMA ApS has published its annual report for 2024. Gross profit came to DKK 24,763,226, and the net result was DKK 3,378,539.
BILLEV PHARMA ApS has published its annual report for 2023. Gross profit came to DKK 29,072,533, and the net result was DKK 4,943,056.
BILLEV PHARMA ApS has published its annual report for 2022. Gross profit came to DKK 30,170,800, and the net result was DKK 6,013,157.
BILLEV PHARMA ApS has published its annual report for 2021. Gross profit came to DKK 25,637,714, and the net result was DKK 5,548,863.
BILLEV PHARMA ApS has published its annual report for 2020. Gross profit came to DKK 21,427,861, and the net result was DKK 3,786,711.
BILLEV PHARMA ApS has published its annual report for 2019. Gross profit came to DKK 17,491,610, and the net result was DKK 2,493,022.
BILLEV PHARMA ApS has published its annual report for 2018. Gross profit came to DKK 17,087,844, and the net result was DKK 3,726,340.
BILLEV PHARMA ApS has published its annual report for 2017. Gross profit came to DKK 14,556,638, and the net result was DKK 2,120,209.
As of June 29, 2016, VAN ARKENS HOLDING ApS is registered as an owner of BILLEV PHARMA ApS with an ownership share of 50%.
As of June 29, 2016, UL JENSEN HOLDING ApS is registered as an owner of BILLEV PHARMA ApS with an ownership share of 50%.
BILLEV PHARMA ApS has published its annual report for 2016. The net result was DKK 2,007,612.
BILLEV PHARMA ApS has published its annual report for 2015. Gross profit came to DKK 9,747,345, and the net result was DKK 636,436.
As of April 30, 2015, Ulrikke Lynge Jensen is registered as director of BILLEV PHARMA ApS.
As of April 30, 2015, Anja Wencke van Arkens is registered as director of BILLEV PHARMA ApS.
As of April 30, 2015, Peter de Mayo Billev has stepped down as director of BILLEV PHARMA ApS.
BILLEV PHARMA ApS has published its annual report for 2014. Gross profit came to DKK 9,724,193, and the net result was DKK 516,674.
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of BILLEV PHARMA ApS.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of BILLEV PHARMA ApS.
BILLEV PHARMA ApS has published its annual report for 2013. Gross profit came to DKK 9,417,221, and the net result was DKK 727,552.
As of September 23, 2010, JUT NR. 2180 A/S has been appointed auditor of BILLEV PHARMA ApS.
As of September 23, 2010, EY Danmark A/S has stepped down as auditor of BILLEV PHARMA ApS.
As of July 22, 1977, EY Danmark A/S has been appointed auditor of BILLEV PHARMA ApS.
As of July 22, 1977, Peter de Mayo Billev is registered as director of BILLEV PHARMA ApS.
BILLEV PHARMA ApS was founded on July 22, 1977.
Companies in the same industry and area
CVR 41744162
CVR 24969355
CVR 31133475
CVR 45960285
CVR 37451835
companydata.dk